2019-01-21T23:24:59Zhttps://digital.csic.es/dspace-oai/requestoai:digital.csic.es:10261/1678052018-07-24T00:55:58Zcom_10261_133com_10261_1col_10261_386EMT in cancerBrabletz, ThomasKalluri, RaghuNieto, M. ÁngelaWeinberg, Robert A.European Research CouncilMinisterio de Economía y Competitividad (España)Ludwig Center of Molecular OncologyBreast Cancer Research FoundationSimilar to embryonic development, changes in cell phenotypes defined as an epithelial to mesenchymal transition (EMT) have been shown to play a role in the tumorigenic process. Although the first description of EMT in cancer was in cell cultures, evidence for its role in vivo is now widely reported but also actively debated. Moreover, current research has exemplified just how complex this phenomenon is in cancer, leaving many exciting, open questions for researchers to answer in the future. With these points in mind, we asked four scientists for their opinions on the role of EMT in cancer and the challenges faced by scientists working in this fast-moving field.2018-07-23T10:34:27Z2018-07-23T10:34:27Z2018-01-12ArtículoNature Reviews Cancer 18: 128-134 (2018)1474-175Xhttp://hdl.handle.net/10261/16780510.1038/nrc.2017.1181474-1768http://dx.doi.org/10.13039/100001006http://dx.doi.org/10.13039/501100003329http://dx.doi.org/10.13039/501100000781enghttp://dx.doi.org/10.1038/nrc.2017.118Síinfo:eu-repo/grantAgreement/EC/FP7/322694MINECO/ICTI2013-2016/BFU2014-53128-RclosedAccessSpringer Nature